ProShare Advisors LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,368
-59.3%
21,550
+5.4%
0.00%
Q2 2023$67,284
-10.9%
20,451
+11.3%
0.00%
Q1 2023$75,550
-36.1%
18,382
-8.8%
0.00%
Q4 2022$118,143
-3.2%
20,161
+11.3%
0.00%
Q3 2022$122,000
+52.5%
18,110
+4.1%
0.00%
Q2 2022$80,000
-9.1%
17,399
-21.1%
0.00%
Q1 2022$88,000
-45.3%
22,048
-14.4%
0.00%
Q4 2021$161,000
-30.3%
25,767
+5.2%
0.00%
-100.0%
Q3 2021$231,000
-43.9%
24,499
-19.3%
0.00%0.0%
Q2 2021$412,000
+7.0%
30,366
+27.7%
0.00%0.0%
Q1 2021$385,000
-35.3%
23,779
+6.3%
0.00%
-50.0%
Q4 2020$595,000
+440.9%
22,364
+103.6%
0.00%
+100.0%
Q3 2018$110,000
-45.3%
10,982
-2.5%
0.00%0.0%
Q2 2018$201,000
+6.9%
11,264
-5.7%
0.00%0.0%
Q1 2018$188,000
-12.1%
11,950
-8.1%
0.00%0.0%
Q4 2017$214,00013,0080.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,663,673$40,026,0004.69%
Opaleye Management Inc. 1,047,000$4,837,0002.18%
Sarissa Capital Management LP 4,299,297$19,863,0002.00%
Decheng Capital Management III (Cayman), LLC 904,268$4,178,0001.58%
SILVERARC CAPITAL MANAGEMENT, LLC 850,000$3,927,0001.21%
Orbimed Advisors 9,011,437$41,633,0000.75%
Avoro Capital Advisors LLC 7,550,000$34,881,0000.69%
Rock Springs Capital Management LP 4,075,958$18,831,0000.55%
Artal Group S.A. 2,200,000$10,164,0000.54%
DAFNA Capital Management LLC 406,763$1,879,0000.51%
View complete list of MERSANA THERAPEUTICS INC shareholders